Close
Close
Close
Close
Close
Close

Our diverse portfolio helps us deliver on our commitment to Women's Health

Our history

Theramex has grown to become a global pharmaceutical company dedicated to Women’s Health in over eighty countries, across five continents.

1954

Theramex is founded by Paul Hamel and based in Monaco

1970

The Theramex brand is established as an independent Women’s Health company, mainly serving France and Italy

1980

Theramex grows and expands its menopause product range

1990

Theramex has successfully developed a presence in 15 new markets

1999

Merck acquires Theramex from François Rougaignon, Paul Hamel Nicolas Guérité and a financial holding company

2000

Merck KGaA acquires Theramex. The company footprint grows to serve over 25 countries

2011

Teva Pharmaceuticals acquires Theramex and introduces the Teva Women’s Health brand

2012

Theramex enters the contraception market with the introduction of a new product. Over the next few years, Theramex develops its product range and expands its portfolio, serving women’s needs in over 50 markets

2018

Teva Women’s Health is sold to CVC Capital Partners. Theramex emerges as an independent company dedicated to creating important treatments in Women’s Health

2019

With a presence in key countries including the UK, France, Germany, Italy, Spain, Benelux and Australia, Theramex expands its reach into The Netherlands, Poland, Slovakia and Romania. In June, Theramex completed separation from Teva in all EU markets

2020

Theramex opens another HQ in Warsaw, Poland.

It also awards five grants to fund research into Assisted Reproductive Medicine

2021 onwards

Theramex plans 3 additional global launches and an expansion of their direct presence into 6 additional markets in Europe and Latin America. Theramex will serve over 80 markets to offer practical and dependable solutions for all women